DARIO ELEVATE
DEAD

Serial Number

97513377

Owner

LABSTYLE INNOVATION LTD.

Attorney

Joseph Agostino

Filing Date

Jul 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DARIO ELEVATE Trademark

Serial Number: 97513377

DARIO ELEVATE is a trademark filed by LABSTYLE INNOVATION LTD. on July 21, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

LABSTYLE INNOVATION LTD. (17 trademarks)

8 HATOKHEN STREET
CAESAREA 3088900 , IL

Entity Type: 16

Trademark Details

Filing Date

July 21, 2022

Registration Date

Not Registered

Published for Opposition

September 17, 2024

Goods & Services

Downloadable medical software for tracking blood data for use in health and wellness treatment and management; Downloadable medical software for patients and healthcare providers to use in collaborating, monitoring, managing, tracking, and communicating concerning health and medical care, wellness, nutrition, weight management, lifestyle management, mental conditions, disease and multiple health and medical conditions treatment and management; Downloadable medical software application for monitoring, tracking and managing health and medical conditions, wellness, nutrition, weight management, lifestyle management, mental conditions, disease and multiple health conditions treatment and management; Downloadable medical software application used on phones, tablets and laptops for tracking blood data for use with sensors, meters, monitors and testers, for use in health and wellness monitor, treatment and management; Software as a Medical Device (SaMD), downloadable, for the treatment and management of diabetes and other multiple medical and health conditions by tracking, monitoring and measuring glucose levels, blood pressure, weight, mental conditions, musculoskeletal conditions and other physiological and medical parameters

Disposable test strips for measuring blood sugar for use in conjunction with blood glucose meters; Disposable test strips for measuring blood sugar for use in conjunction with meters for hypertension, weight, musculoskeletal conditions; Medical monitoring devices, namely, diagnostic test strips for use in the fields of blood analysis, hypertension, musculoskeletal conditions, weight and mental condition; Medical monitoring and support devices, namely, diagnostic test strips for use in the fields of chronic conditions, namely, diabetes, hypertension, weight, musculoskeletal conditions, heart conditions, and blood conditions; Medical monitoring devices, namely, diagnostic test strips used in conjunction with medical apparatus for tracking, monitoring, measuring and managing diabetes, blood glucose levels, blood pressure, PH levels and white blood cell concentrations

Health and wellness condition sensors, meters, monitors and testers, namely, blood glucose meters and blood testing apparatus; Blood glucose meters; blood glucose monitoring system comprised of blood glucose meters, lancets, and glucose test strips; sensors and testing means for medical condition and wellness monitoring and tracking, namely, patient monitoring sensors and blood testing apparatus; Biometric and biofeedback sensors for use in conjunction with blood glucose meters; Biometric and biofeedback sensors and monitors for medical use used for tracking, measuring, monitoring and managing various health and wellness conditions, namely, diabetes, blood glucose levels, blood pressure, hypertension, weight, diet, obesity, nutrition, musculoskeletal conditions, mental conditions and multiple chronic conditions of the foregoing; Monitors and sensors used to measure biometric data for medical use; Bio-sensors being sensors for collecting, compiling and analyzing clinical and biological data, for medical purposes; Medical products, namely, sensors for real time data input apparatus, namely, sensors for gathering human biometric data, blood properties, respiratory events, monitoring heart rate and concentrations in fluids; Medical patient monitoring sensor apparatus for monitoring, tracking and managing various health and wellness conditions, nutrition, weight, and musculoskeletal conditions; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties, respiratory events and other health and wellness conditions, namely diabetes, hypertension, weight and musculoskeletal conditions; Medical apparatus and instruments to measure and monitor blood pressure, cardiac output, musculoskeletal conditions and other physiological and cardiovascular parameters in the nature of heartrate and weight; Medical devices for blood analysis; Meters, monitors and sensors for measuring blood pressure, weight and body movements for use in conjunction with hypertension, musculoskeletal conditions, weight and mental condition; Medical devices for monitoring blood pressure, weight and body movements for hypertension, musculoskeletal conditions, weight and mental condition; Medical devices for tracking, monitoring, and measuring chronic conditions of patients, namely, diabetes, hypertension, weight, musculoskeletal conditions, heart conditions, and blood conditions for supporting such patients with such chronic conditions; Medical apparatus for tracking, monitoring, and measuring physiological and medial parameters, namely, diabetes, blood glucose levels, blood pressure, and PH levels.

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 16, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 16, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 24, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 24, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 24, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 24, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 31, 2024 GNFN
FINAL REFUSAL E-MAILED
May 31, 2024 GNFR
FINAL REFUSAL WRITTEN
May 31, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 18, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 18, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2023 CNRT
ASSIGNED TO EXAMINER
May 8, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 27, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 27, 2023 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 27, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 27, 2023 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2022 NWOS
NEW APPLICATION ENTERED
Jul 25, 2022 NWAP